237 related articles for article (PubMed ID: 2165834)
1. SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat.
Smith EF; Slivjak MJ; Egan JW; Eckardt RD; Newton JF
Br J Pharmacol; 1990 Jun; 100(2):195-200. PubMed ID: 2165834
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
Smith EF; Slivjak MJ; Eckardt RD; Newton JF
J Pharmacol Exp Ther; 1989 Jun; 249(3):805-11. PubMed ID: 2543811
[TBL] [Abstract][Full Text] [Related]
3. ICI 198615 is an antagonist of leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat.
Smith EF; Slivjak MJ
Pharmacology; 1990; 41(2):57-66. PubMed ID: 2175920
[TBL] [Abstract][Full Text] [Related]
4. Evidence for high and low affinity leukotriene D4 receptors mediating vascular responses in the conscious rat.
Smith EF; Slivjak MJ
Eur J Pharmacol; 1989 Jan; 159(3):297-301. PubMed ID: 2537739
[TBL] [Abstract][Full Text] [Related]
5. The effect of inhalation of the leukotriene receptor antagonist, SK&F 104353, on leukotriene C4- and leukotriene E4-induced bronchoconstriction in subjects with asthma.
Christie PE; Spur BW; Lee TH
J Allergy Clin Immunol; 1991 Aug; 88(2):193-8. PubMed ID: 1652604
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pig.
Hay DW; Muccitelli RM; Vickery-Clark LM; Novak LS; Osborn RR; Gleason JG; Yodis LA; Saverino CM; Eckardt RD; Sarau HM
Pulm Pharmacol; 1991; 4(3):177-89. PubMed ID: 1668219
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.
Hay DW; Muccitelli RM; Tucker SS; Vickery-Clark LM; Wilson KA; Gleason JG; Hall RF; Wasserman MA; Torphy TJ
J Pharmacol Exp Ther; 1987 Nov; 243(2):474-81. PubMed ID: 2824747
[TBL] [Abstract][Full Text] [Related]
8. The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.
Torphy TJ; Newton JF; Wasserman MA; Vickery-Clark L; Osborn RR; Bailey LS; Yodis LA; Underwood DC; Hay DW
J Pharmacol Exp Ther; 1989 May; 249(2):430-7. PubMed ID: 2542530
[TBL] [Abstract][Full Text] [Related]
9. Concentration-dependent, stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with the peptidoleukotriene receptor antagonist SK & F 104353.
Smith EF; Kinter LB; Jugus M; Eckardt RD; Newton JF
Eicosanoids; 1989; 2(2):101-7. PubMed ID: 2560662
[TBL] [Abstract][Full Text] [Related]
10. Action of peptidoleukotrienes on ion transport in rabbit distal colon in vitro.
Jett MF; Marshall P; Fondacaro JD; Smith PL
J Pharmacol Exp Ther; 1991 May; 257(2):698-705. PubMed ID: 1851834
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of a specific leukotriene receptor antagonist in splanchnic artery occlusion shock.
Lento PH; Saukkonen K; Aoki N; Lefer AM; Slivjak MJ; Smith EF
Eur J Pharmacol; 1989 Jun; 165(2-3):241-9. PubMed ID: 2550251
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of leukotrienes C4, D4, and E4 in the pulmonary and systemic vasculature of sheep.
Ahmed T; Marchette B; Wasserman M; Wanner A; Yerger L
Bull Eur Physiopathol Respir; 1986; 22(6):573-80. PubMed ID: 3030470
[TBL] [Abstract][Full Text] [Related]
13. SK&F 104353: selective antagonism of peptidoleukotrine-induced changes in electrolyte transport by rat ileal mucosa in vitro.
Elton E; Chiossone DC; McCafferty GP; Ryan FM; Smith PL
J Pharmacol Exp Ther; 1989 Nov; 251(2):484-9. PubMed ID: 2553922
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological evaluation of LY 170680, a novel leukotriene D4 and E4 antagonist in the guinea-pig.
Boot JR; Bond A; Gooderham R; O'Brien A; Parsons M; Thomas KH
Br J Pharmacol; 1989 Sep; 98(1):259-67. PubMed ID: 2553189
[TBL] [Abstract][Full Text] [Related]
15. Characterization of LTC4 effects on rabbit ileal mucosa in vitro.
Smith PL; Chiossone DC; McCafferty GP
Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):94-100. PubMed ID: 2156177
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of leukotriene C4, D4 and E4 in allergic inflammation in rats.
Ohuchi K; Takahashi C; Watanabe M; Hirasawa N; Suzuki Y; Kudo M; Konishi T; Tsurufuji S
J Clin Lab Immunol; 1988 Dec; 27(4):171-8. PubMed ID: 2855079
[TBL] [Abstract][Full Text] [Related]
17. Cysteinyl leukotriene actions on the microcirculation of the normal and split hydronephrotic rat kidney.
Gulbins E; Parekh N; Rauterberg EW; Schlottmann K; Steinhausen M
Eur J Clin Invest; 1991 Apr; 21(2):184-96. PubMed ID: 1647953
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations.
Cheng JB; Lang D; Bewtra A; Townley RG
J Pharmacol Exp Ther; 1985 Jan; 232(1):80-7. PubMed ID: 2981321
[TBL] [Abstract][Full Text] [Related]
19. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
Mong S; Wu HL; Miller J; Hall RF; Gleason JG; Crooke ST
Mol Pharmacol; 1987 Aug; 32(1):223-9. PubMed ID: 3039338
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the peptido-leukotriene receptor PL2 on the ferret spleen strip.
Gardiner PJ; Norman P; Cuthbert NJ; Tudhope SR; Abram TS
Eur J Pharmacol; 1993 Jul; 238(1):19-26. PubMed ID: 8405079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
